Research has found that it can take more than six months for professional athletes to return to play after being treated for a deep-vein thrombosis or pulmonary embolism.
The health-insurance giant said its medical-cost ratio was 88.4% in the third quarter of this year, as the company tries to rein in spending on medical care.
